Do women with cancer have better survival as compared to men after adjusting for staging distribution?

European Journal of Public Health
Willi Oberaigner, Uwe Siebert

Abstract

Gender aspects in medicine are receiving increasing attention, namely also in oncology. For this reason, we decided to investigate whether for solid cancer sites women have better survival outcome than do men in the population of Tyrol, Austria. We conducted an observational population-based study in Tyrol. All solid cancer sites excluding non-melanoma skin cancer and sex-specific sites were analysed in total and all specific sites with more than 500 patients in the analysis. By the end of 2006, follow-up was ended. We applied a relative excess risk model, thus correcting for differences in life expectancy between women and men. For all cancer sites combined, after adjusting for case mix, women had a relative excess risk of 0.95 (95% CI 0.91-0.99). For the following sites our analysis resulted in a relative excess risk statistically different from 1, namely for women as compared to men: head and neck without larynx 0.72 (95% CI 0.56-0.93), stomach 0.86 (95% CI 0.75-0.97) and lung 0.82 (95% CI 0.75-0.90). In a healthcare system with free access to diagnostics and therapy, after adjusting for staging distribution female cancer patients have a lesser excess mortality risk than do men for lung, stomach and head and neck cancer and ...Continue Reading

References

Aug 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K AntmanE Frei
Apr 1, 1984·Statistics in Medicine·F E HarrellR A Rosati
Feb 1, 1997·Journal of Clinical Epidemiology·H Brenner, O Gefeller
Mar 10, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A MicheliP Muti
Jun 7, 2000·Urology·N A MunganL A Kiemeney
Aug 8, 2001·The British Journal of Surgery·M W WichmannUNKNOWN Colorectal Cancer Study Group
Mar 27, 2002·International Journal of Epidemiology·Stephen R Cole, Miguel A Hernán
Dec 19, 2003·Journal of Clinical Epidemiology·Hermann Brenner, Timo Hakulinen
Dec 26, 2003·Statistics in Medicine·Paul W DickmanTimo Hakulinen
May 14, 2005·Stroke; a Journal of Cerebral Circulation·Petra DickMartin Schillinger
Jul 30, 2005·British Journal of Cancer·H Brenner, T Hakulinen
Aug 24, 2005·Gender Medicine·José M ChatkinJose A L F Pinto
Nov 22, 2005·Lancet·Goodarz DanaeiUNKNOWN Comparative Risk Assessment collaborating group (Cancers)
Apr 8, 2006·BMJ : British Medical Journal·Anna BarfordMary Shaw
Apr 25, 2006·Annals of Surgery·Charles R ScogginsUNKNOWN Sunbelt Melanoma Trial
Nov 15, 2006·Wiener medizinische Wochenschrift·Judith Karner-Hanusch, Brigitte Marian
Aug 19, 2007·Methods of Information in Medicine·W Oberaigner
Dec 26, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A MicheliUNKNOWN EUROCARE Working Group

❮ Previous
Next ❯

Citations

Sep 12, 2015·Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen·Uwe SiebertUNKNOWN Oncotyrol HTA & Outcomes Research Working Group
Apr 18, 2015·BMC Cancer·Kaire InnosTiiu Aareleid
Feb 18, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J A Avilés-IzquierdoE Mercader-Cidoncha
Jul 19, 2017·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·M D ChirlaqueUNKNOWN REDECAN Working Group
Sep 9, 2018·Cancer Causes & Control : CCC·Nina AfsharRoger L Milne
Aug 29, 2019·International Journal of Environmental Research and Public Health·Marie-Pier Bergeron-BoucherMaarten Jan Wensink
Jun 18, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kevin D BoydGareth J Morgan
May 1, 2020·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Michelle DongJill S Barnholtz-Sloan
Dec 29, 2020·Life Sciences·Sravanthi DavuluriKshitish K Acharya
Jul 16, 2020·Clinical Lung Cancer·Guilherme Jorge CostaLuiz Cláudio Santos Thuler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Michael B CookWilliam F Anderson
Annals of Oncology : Official Journal of the European Society for Medical Oncology
E de VriesJ-W W Coebergh
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
A MicheliEUROCARE Working Group
© 2021 Meta ULC. All rights reserved